Transdigm Group INC Form 4 insider transactions

TransDigm Group Inc. director Michael Graff was granted 518 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026, contingent on performance targets.

TransDigm Group Director Sean Hennessy was granted 518 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026, contingent on performance targets.

TransDigm Group Director W. Nicholas Howley was granted 518 stock options with a $1,291.97 exercise price, vesting over five years based on performance targets.

TransDigm Group Director Gary McCullough received 518 stock options with a $1,291.97 exercise price, vesting over five years based on performance targets.

TransDigm Group Director Peter Palmer reported the acquisition of 518 stock options with a $1,291.97 exercise price, vesting over five years contingent on performance targets.

TransDigm Group Director Michele Santana was granted 518 stock options, exercisable over five years starting September 30, 2026, contingent on annual operating performance targets.

TransDigm Group Director Robert J. Small was granted 518 stock options with an exercise price of $1,291.97, vesting over five years contingent on performance targets.

TransDigm Group Director Kevin Stein was granted 518 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026, contingent on performance targets.

TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, acquired 26,450 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026.

TransDigm Group's General Counsel, Armani Vadiee, acquired 17,100 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026.

TransDigm Group's Chief Financial Officer, Sarah Wynne, was granted 8,700 stock options with an exercise price of $1,291.97, exercisable in 2029 and 2030.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, was granted 9,700 stock options with an exercise price of $1,291.97, exercisable in 2029 and 2030.

TransDigm Group's President and CEO, Michael Lisman, was granted 79,603 stock options with an exercise price of $1,291.97, exercisable over future years subject to performance targets.

TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options and subsequently sold a portion of the acquired common stock.

TransDigm Group Director Kevin Stein executed a pre-planned sale of 700 common shares after exercising stock options.

TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options and subsequently sold 580 shares of common stock under a Rule 10b5-1 plan.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold an equivalent number of shares under a pre-arranged 10b5-1 plan.

TransDigm Group Director W. Nicholas Howley exercised stock options and simultaneously sold an equal number of common shares under a Rule 10b5-1 plan.

TransDigm Group Co-Chief Operating Officer Joel Reiss exercised stock options and subsequently sold 3,000 shares of common stock under a pre-arranged 10b5-1 plan.

TransDigm Group director Robert J. Small filed an amended Form 4 to correct the reported amount of common stock directly owned.

TransDigm Group Director Michele Santana acquired 29 shares of common stock, valued at $1,288.13 per share, as part of her semi-annual director fee.

TransDigm Group Director Sean P. Hennessy acquired 36 shares of common stock as part of his semi-annual director fee.

TransDigm Group Director Michael Graff acquired 29 shares of common stock valued at $1,288.13 per share as part of his semi-annual director fee.

TransDigm Director Jane M. Cronin acquires 29 shares for fee.

TransDigm Group Director David Barr acquired 36 shares of common stock on September 19, 2025, as part of his semi-annual director fee, bringing his total beneficial ownership to 32,138 shares.

TransDigm Group Director Robert J. Small acquired 44 shares of common stock on September 19, 2025, as part of his semi-annual director compensation.

TransDigm Group director W. Nicholas Howley exercised stock options and subsequently sold 2,736 shares of common stock through a 10b5-1 plan.

TransDigm Group Director Robert J. Small reported significant sales of company common stock by entities he manages and a personal gift of shares.

TransDigm Group Director Robert J. Small reported a distribution of 2,318 common shares from Stockbridge Fund, L.P. to its partners.

TransDigm Group Director Michael Graff exercised stock options and subsequently sold an equal number of shares for approximately $1,400 per share.